Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif Bjermer

Showing results (111-120 of 272) with videos related to

Pageof 28
Sort By:
International Immunopharmacology|May 1, 2012
Capacity of capsazepinoids to relax human small airways and inhibit TLR3-induced TSLP and IFNβ production in diseased bronchial epithelial cellsIrma Mahmutovic-Persson, Martin Johansson, Angelica Brandelius, et al.
Respiratory Medicine|December 20, 2025
ADAM17 and related epithelial injury markers in bronchoalveolar lavage and blood distinguish COPD from controlsCarin E Lau, Nicole M D van der Burg, Jaro Ankerst, et al.
Scientific Reports|November 10, 2023
Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitisCarl Skröder, Laila Hellkvist, Åslög Dahl, et al.
Respiratory Research|June 19, 2016
Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studiesDave Singh, Mina Gaga, Olaf Schmidt, et al.
Pulmonary Pharmacology & Therapeutics|September 13, 2015
iNOS affects matrix production in distal lung fibroblasts from patients with mild asthmaAnna-Karin Larsson-Callerfelt, Maria Weitoft, Kristian Nihlberg, et al.
Journal of Translational Medicine|August 31, 2015
Rhinoviral stimuli, epithelial factors and ATP signalling contribute to bronchial smooth muscle production of IL-33Jenny Calvén, Hamid Akbarshahi, Mandy Menzel, et al.
American Journal of Respiratory and Critical Care Medicine|April 7, 2015
IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid NeogenesisAbraham B Roos, Caroline Sandén, Michiko Mori, et al.
European Clinical Respiratory Journal|December 23, 2015
Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung diseaseAnders Løkke, Lars Ahlbeck, Leif Bjermer, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 20, 2016
The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study)Kai-Michael Beeh, Eric Derom, José Echave-Sustaeta, et al.
The American Journal of Pathology|November 26, 2019
Comparison of Normal and Metaplastic Epithelium in Patients with Stable versus Persistently Symptomatic Severe Asthma Using Laser-Capture Microdissection and Data-Independent Acquisition-Mass SpectrometryMaria Weitoft, Catharina Müller, Emma Åhrman, et al.
Pageof 28

Showing results (111-120 of 272) with videos related to

Sort By:
Pageof 28
International Immunopharmacology|May 1, 2012
Capacity of capsazepinoids to relax human small airways and inhibit TLR3-induced TSLP and IFNβ production in diseased bronchial epithelial cellsIrma Mahmutovic-Persson, Martin Johansson, Angelica Brandelius, et al.
Respiratory Medicine|December 20, 2025
ADAM17 and related epithelial injury markers in bronchoalveolar lavage and blood distinguish COPD from controlsCarin E Lau, Nicole M D van der Burg, Jaro Ankerst, et al.
Scientific Reports|November 10, 2023
Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitisCarl Skröder, Laila Hellkvist, Åslög Dahl, et al.
Respiratory Research|June 19, 2016
Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studiesDave Singh, Mina Gaga, Olaf Schmidt, et al.
Pulmonary Pharmacology & Therapeutics|September 13, 2015
iNOS affects matrix production in distal lung fibroblasts from patients with mild asthmaAnna-Karin Larsson-Callerfelt, Maria Weitoft, Kristian Nihlberg, et al.
Journal of Translational Medicine|August 31, 2015
Rhinoviral stimuli, epithelial factors and ATP signalling contribute to bronchial smooth muscle production of IL-33Jenny Calvén, Hamid Akbarshahi, Mandy Menzel, et al.
American Journal of Respiratory and Critical Care Medicine|April 7, 2015
IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid NeogenesisAbraham B Roos, Caroline Sandén, Michiko Mori, et al.
European Clinical Respiratory Journal|December 23, 2015
Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung diseaseAnders Løkke, Lars Ahlbeck, Leif Bjermer, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 20, 2016
The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study)Kai-Michael Beeh, Eric Derom, José Echave-Sustaeta, et al.
The American Journal of Pathology|November 26, 2019
Comparison of Normal and Metaplastic Epithelium in Patients with Stable versus Persistently Symptomatic Severe Asthma Using Laser-Capture Microdissection and Data-Independent Acquisition-Mass SpectrometryMaria Weitoft, Catharina Müller, Emma Åhrman, et al.
Pageof 28